274 related articles for article (PubMed ID: 16257170)
1. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
Van Manen L; Feldman-Stewart D; Brundage MD
Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
[TBL] [Abstract][Full Text] [Related]
2. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
4. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based patient choice: a prostate cancer decision aid in plain language.
Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
7. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
Davison BJ; Goldenberg SL; Gleave ME; Degner LF
Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
[TBL] [Abstract][Full Text] [Related]
8. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer treatment decisions: a focus group exploration.
O'Rourke ME; Germino BB
Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
[TBL] [Abstract][Full Text] [Related]
10. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
Feldman-Stewart D; Brennenstuhl S; Brundage MD
Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
[TBL] [Abstract][Full Text] [Related]
11. Information and decision-making preferences of men with prostate cancer.
Davison BJ; Degner LF; Morgan TR
Oncol Nurs Forum; 1995 Oct; 22(9):1401-8. PubMed ID: 8539181
[TBL] [Abstract][Full Text] [Related]
12. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.
Davison BJ; Goldenberg SL; Wiens KP; Gleave ME
Cancer Nurs; 2007; 30(5):E7-15. PubMed ID: 17876177
[TBL] [Abstract][Full Text] [Related]
13. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
Williams-Piehota PA; McCormack LA; Treiman K; Bann CM
Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
[TBL] [Abstract][Full Text] [Related]
14. Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer.
Snow SL; Panton RL; Butler LJ; Wilke DR; Rutledge RD; Bell DG; Rendon RA
Urology; 2007 May; 69(5):941-5. PubMed ID: 17482939
[TBL] [Abstract][Full Text] [Related]
15. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests.
Schapira MM; VanRuiswyk J
J Fam Pract; 2000 May; 49(5):418-24. PubMed ID: 10836772
[TBL] [Abstract][Full Text] [Related]
16. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
17. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
19. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
Farrell MH; Murphy MA; Schneider CE
Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
[TBL] [Abstract][Full Text] [Related]
20. An approach to measuring the quality of breast cancer decisions.
Sepucha K; Ozanne E; Silvia K; Partridge A; Mulley AG
Patient Educ Couns; 2007 Feb; 65(2):261-9. PubMed ID: 17023138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
